Edward P. Acosta

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 26 papers. Top paper: “Antiviral therapy: Valacyclovir Treatment of Alzheimer’s Disease (VALAD) Trial: protocol for a randomised, double-blind,placebo-controlled, treatment trial”.

Antiviral therapy: Valacyclovir Treatment of Alzheimer’s Disease (VALAD) Trial: protocol for a randomised, double-blind,placebo-controlled, treatment trial

BMJ Open(2020)10.1136/bmjopen-2019-032112

N/A

2.3DataRank · unranked

82 citations

Howard Andrews, William Charles Kreisl, Qolamreza Razlighi, Anne A. Gershon, Yaakov Stern +11 more

A Phase 1/2 Randomized, Placebo-Controlled Trial of Romidespin in Persons With HIV-1 on Suppressive Antiretroviral Therapy

The Journal of Infectious Diseases(2020)10.1093/infdis/jiaa777

N/A

1.5DataRank · unranked

48 citations

Lu Zheng, Joshua C. Cyktor, Evgenia Aga, Bernard Macatangay, Catherine Godfrey +10 more

Predictors of HIV rebound differ by timing of antiretroviral therapy initiation

JCI Insight(2024)10.1172/jci.insight.173864

N/A

0.720DataRank · unranked

27 citations

Meghan Melberg, Autumn Kittilson, Mohamed Abdel‐Mohsen, Yijia Li, Evgenia Aga +21 more

Pharmacokinetics, safety, and tolerability of dispersible and immediate-release abacavir, dolutegravir, and lamivudine tablets in children with HIV (IMPAACT 2019): week 24 results of an open-label, multicentre, phase 1–2 dose-confirmation study

The Lancet HIV(2023)10.1016/s2352-3018(23)00107-8

N/A

0.675DataRank · unranked

13 citations

Jennifer J. Kiser, Lauren Ziemba, S. M. Ward, Yasha Rani, Tim R. Cressey +24 more

Ivacaftor for Chronic Obstructive Pulmonary Disease: Results from a Phase 2, Randomized Controlled Trial

American Journal of Respiratory and Critical Care Medicine(2024)10.1164/rccm.202407-1302oc

N/A

0.374DataRank · unranked

5 citations

George M. Solomon, Jennifer S. Guimbellot, Edward P. Acosta, Pradeep G. Bhambhavni, Sharon White +9 more

Effectiveness of a city-wide program to prevent mother-to-child HIV transmission in Lusaka, Zambia

UNC Libraries(2020)10.17615/vjvw-yw05

N/A

0DataRank · unranked

0 citations

Jens Levy, Courtney C. Maclean, Sten H. Vermund, Jeffrey S. A. Stringer, Stringer, Elizabeth +5 more

Less Bone Loss With Maraviroc- Versus Tenofovir-Containing Antiretroviral Therapy in the AIDS Clinical Trials Group A5303 Study

UNC Libraries(2020)10.17615/14ka-fe90

N/A

0DataRank · unranked

0 citations

Todd T. Brown, Aleshia Thomas, Joseph J. Eron, Athe Tsibris, Andrea Weiss +82 more

Ivacaftor-elexacaftor-tezacaftor and tacrolimus combination in cystic fibrosis

Journal of Cystic Fibrosis(2021)10.1016/j.jcf.2021.05.008

N/A

0DataRank · unranked

22 citations

Kevin J. Ryan, Hector Gutierrez, Luz Helena Gutierrez Sanchez, Janaina Nogueira Anderson, Edward P. Acosta +3 more

Does oxaliplatin pharmacokinetics (PKs) explain associations between body composition and chemotherapy toxicity risk in older adults with gastrointestinal (GI) cancers?

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.3095

N/A

0DataRank · unranked

11 citations

Mustafa Al‐Obaidi, Joseph E. Rower, Christian Harmon, Chen Dai, Edward P. Acosta +9 more

Systemic Administration of a Brain Permeable Cdk5 Inhibitor Alters Neurobehavior

Frontiers in Pharmacology(2022)10.3389/fphar.2022.863762

N/A

0DataRank · unranked

23 citations

Sarbjit Singh, Kevin J. Ryan, Ayanabha Chakraborti, Florian Plattner, Yogesh A. Sonawane +5 more

Quantitation of cystic fibrosis triple combination therapy, elexacaftor/tezacaftor/ivacaftor, in human plasma and cellular lysate

Journal of Chromatography B(2022)10.1016/j.jchromb.2022.123518

N/A

0DataRank · unranked

21 citations

Jennifer S. Guimbellot, Alexander E. Dowell, Kedria D. Reed-Walker, Corenna Kerstner-Wood, Justin D. Anderson +3 more

Plasma and cellular ivacaftor concentrations in patients with cystic fibrosis

Pediatric Pulmonology(2022)10.1002/ppul.26093

N/A

0DataRank · unranked

11 citations

Kevin J. Ryan, Justin D. Anderson, Kennedy L. Parker, L. Victoria Odom, Steven M. Rowe +2 more

HIV post-treatment controllers have distinct immunological and virological features

Proceedings of the National Academy of Sciences(2023)10.1073/pnas.2218960120

N/A

0DataRank · unranked

65 citations

Xiaoming Sun, Yijia Li, Meghan Melberg, Daniela Moïsi, Rachel Gottlieb +23 more

440 Ivacaftor metabolites in epithelia

Journal of Cystic Fibrosis(2023)10.1016/s1569-1993(23)01366-8

N/A

0DataRank · unranked

0 citations

A. Dowell, Kevin J. Ryan, J. Anderson, Edward P. Acosta, Jennifer S. Guimbellot

Pharmacokinetic variability of CFTR modulators from standard and alternative regimens

Pulmonary Pharmacology & Therapeutics(2024)10.1016/j.pupt.2024.102301

N/A

0DataRank · unranked

11 citations

A. Chalamalla, Bryan Garcia, Stefanie Krick, Jonathan Bergeron, Hossein Sadeghi +6 more

Evaluating the effects of ivacaftor exposure on Staphylococcus aureus small colony variant development and antibiotic tolerance

JAC-Antimicrobial Resistance(2024)10.1093/jacamr/dlae185

N/A

0DataRank · unranked

2 citations

Kendall M Shaffer, Johnathan D. Keith, Ashley M. Oden, Alexander E. Dowell, Kevin J. Ryan +5 more

Impact of Genetic Variants in ABCG2, NR1I2, and UGT1A1 on the Pharmacokinetics of Dolutegravir in Children

JAIDS Journal of Acquired Immune Deficiency Syndromes(2024)10.1097/qai.0000000000003358

N/A

0DataRank · unranked

6 citations

Sean S. Brummel, Audrey N. Chang, Andrew Wiznia, Theodore Ruel, Edward P. Acosta +2 more

Pilot and feasibility study of dietary composition with elexacaftor‐tezacaftor‐ivacaftor concentrations in people with cystic fibrosis

Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy(2024)10.1002/phar.4630

N/A

0DataRank · unranked

2 citations

Julianna Bailey, Justin D. Anderson, A. Chalamalla, Kevin J. Ryan, Edward P. Acosta +2 more

Differential distribution of ivacaftor and its metabolites in plasma and human airway epithelia

Pulmonary Pharmacology & Therapeutics(2024)10.1016/j.pupt.2024.102314

N/A

0DataRank · unranked

1 citations

Justin D. Anderson, Natalie R. Rose, Elizabeth Baker, Alexander E. Dowell, Kevin J. Ryan +3 more

Long-acting Injectable Containing Lopinavir Eliminates Reliance on Ritonavir Pharmacokinetic Enhancement

The Journal of Infectious Diseases(2025)10.1093/infdis/jiaf319

N/A

0DataRank · unranked

1 citations

Charles Flexner, Zachary R. Stephen, Edward P. Acosta, Rachel Bender Ignacio, Rodney J. Y. Ho +1 more

HIV post-treatment controllers have distinct immunological and virological features

UNC Libraries(2025)10.17615/aeyv-ay79

N/A

0DataRank · unranked

0 citations

David M. Margolis, Paul A. Volberding, Joseph J. Eron, Jeffrey M. Jacobson, Rachel Gottlieb +23 more

Pharmacokinetics of oral bromocriptine in postpartum patients

Pregnancy(2025)10.1002/pmf2.70199

N/A

0DataRank · unranked

0 citations

Yuanfan Ye, Kevin J. Ryan, Jeff M. Szychowski, Natalie A. Bello, Karen Sliwa +3 more

Selective Targeting of the Hedgehog Signaling Pathway by PBM Nanoparticles in Docetaxel-Resistant Prostate Cancer

Cells(2020)10.3390/cells9091976

N/A

0DataRank · unranked

29 citations

Jennifer Gordetsky, Sejong Bae, Edward P. Acosta, James W. Lillard, Rajesh Singh +1 more

Toward Consensus on Correct Interpretation of Protein Binding in Plasma and Other Biological Matrices for COVID‐19 Therapeutic Development

Clinical Pharmacology & Therapeutics(2020)10.1002/cpt.2099

N/A

0DataRank · unranked

27 citations

David Back, Charles Flexner, Peter Sjö, Terrence F. Blaschke, Peter Horby +5 more

Implications of Efavirenz Pharmacogenetics When Switching From Efavirenz- to Dolutegravir-containing Antiretroviral Regimens

Clinical Infectious Diseases(2020)10.1093/cid/ciaa975

N/A

0DataRank · unranked

5 citations

Edward P. Acosta, David W. Haas

Efficacy of a nucleoside-sparing regimen of darunavir/ritonavir plus raltegravir in treatment-naive HIV-1-infected patients (ACTG A5262)

UNC Libraries(2020)10.17615/h20d-xc88

N/A

0DataRank · unranked

0 citations

Peter S. Kim, Sébastien Gallien, Joseph J. Eron, Babafemi Taiwo, Edward P. Acosta +6 more